Asem Mohiuddin, M.D., F.R.C.R., F.A.C.R.
Scottsdale, Arizona
Email: asemuddin@gmail.com
Meet Our Experts: Dr. Asem Mohiuddin
Dr. Asem Mohiuddin is a distinguished radiation oncologist whose career has been defined by a relentless pursuit of excellence in cancer care, research, and education. With advanced training from some of the world’s leading institutions, including the Royal Marsden Hospital in London and the Royal College of Radiology, Dr. Mohiuddin has consistently pushed the boundaries of clinical innovation and compassionate care.
A recognized leader in his field, Dr. Mohiuddin has held key positions as Director, Chairman, and Professor at prestigious institutions. His work in clinical trials, groundbreaking research, and the development of state-of-the-art treatment protocols has made significant contributions to the advancement of radiation oncology. His scholarly output, marked by hundreds of peer-reviewed publications and presentations, reflects a career dedicated to enhancing patient outcomes through precision medicine and evidence-based practice.
Beyond his clinical and academic accomplishments, Dr. Mohiuddin is deeply committed to his faith, which informs his compassionate approach to patient care. He believes that integrating spiritual values with scientific expertise creates a unique framework for healing—one that respects the dignity of every individual and nurtures both body and soul.
Dr. Mohiuddin’s leadership, expertise, and unwavering commitment to service continue to inspire colleagues, trainees, and patients alike. His journey is a powerful reminder that excellence in medicine comes not only from technical proficiency but also from a heartfelt dedication to others’ well-being.
My journey – Lesson for the next generation
I was born in Hyderabad, India, and educated there, graduating from Osmania University, Hyderabad, with an M.B.B.S. degree. Thereafter, I trained in England at the Royal Marsden Hospital. At that time, RMH was one of the premier cancer centers in the world. It was a period before the tremendous technological transformation had hit the world stage. It was a time when there were no computers, no internet, no CT scanners, and no advanced treatment delivery systems. My mentors were outstanding clinicians. Their skill came from being lifelong students of the disease and learning its patterns of presentation and evolution. From them, I knew that to succeed in my field, there were three essential elements: observation, documentation, and analysis. “Learn from your patients; they will be your best teachers,” they would tell me, and this became a fundamental core of my subsequent career.
Being a young physician in a busy group of senior practitioners, I had more time to learn about emerging technologies and was able to take advantage of and incorporate them into treatment plans. First, it was the introduction of computers (PDP-11s as big as a whole room), then high-energy linear accelerators for treatment. In an effort to better understand cancer, I also spent time in the biology research labs. The combination of clinical skills I learned from the seniors and the technical know-how of computerized treatment planning, combined with a better understanding of the biology of the disease, gave me instantaneous recognition. I ended up mentoring many of the new entrants to the field, as well as the many international visitors who came to the Marsden to study.
I rapidly advanced to the position of Senior Registrar. I obtained my Fellowship degree from the Royal College, but I had also reached my ceiling for professional advancement in England because of my ethnicity. On the advice of some of the consultants, I applied for positions in the United States. Although I had several offers from prestigious institutions, I chose to join the faculty at Thomas Jefferson Medical College because of the open-minded, progressive leadership of the Department Chair, Dr. Simon Kramer. He had been instrumental in establishing the Radiation Therapy Oncology Group to undertake collaborative national clinical trials in cancer in the US. I took the opportunity to implement many of my ideas in clinical practice, drawing on my knowledge of biology and physics. I was the principal investigator of several national clinical trials conducted by the RTOG, NSABP, and GOG, as well as at the institutional level. I always kept my focus on observation, documentation, and analysis. The latter allowed me to publish extensively, and in a career spanning four decades, I would publish over 350 articles, chapters, and observations. I served on various panels of the National Cancer Institute and was a board examiner for the American Board of Radiology for twenty-five years.
Much of my work was based on patterns of disease failure and how to meet these challenges. In effect, I was rarely writing about outcomes of the current status quo of treatments but more about how to anticipate and overcome failure patterns. This, in effect, challenged the prevalent orthodoxy amongst my peers, and I was more often considered a maverick. The question in my mind was always not how many we cure but how many we fail to cure. This quest also made me open to early adoption of new imaging technologies (CT/MRI, etc.) and to greater proficiency in treatment delivery systems as more powerful computers came online. This open-minded approach to new ideas was another key to my successful career and a lesson for all of us. Despite being considered an outsider, I gained significant national and international recognition for my contributions and was voted among the best cancer specialists in the United States by my peers in publications such as Good Housekeeping, Cosmopolitan, and others. During my career, I mentored numerous students, residents, and other specialists.
Another key lesson I learned was that fame is ephemeral (short-lived). You can rarely stay relevant based on your one great idea. You have to innovate, refine, and bring forth new ideas constantly. Apple computers are a great example. It is why there are constant new hardware and software upgrades. This was another focus of my career that kept me relevant at every step of my working life. Not only did it lead to career success, but it also gave me tremendous satisfaction to know that I had introduced new ideas that benefited humanity. I had learned not to be disheartened by early rejections of my new methods of looking at cancer and its treatment. My happiness came from the benefit it provided to my patients. It took almost 20 years for many of my ideas to be incorporated into today’s standardized therapies. My success was due to my patience, not the accolades of my peers.
Finally, I also learned that not every idea ends in grand success. Many good ideas fail, but these are really learning opportunities. I knew that cancer is a tough disease to conquer. Very early in my career, I learned a crucial lesson that despite my best efforts, I am not the determinant of who survives and who dies. Many patients that I thought would do well died of their disease, and many patients with advanced disease that I had little hope of curing did well. The outcome, I realized, is in the hands of the Almighty. My role is to apply my knowledge and abilities to the best of my ability to help my patients, and to trust in Allah’s help for success. My achievements were really a gift from Allah, just as he had guided my career. He it is who is truly to be praised.